Intercept (ICPT) Rises 16.51% on August 5

Equities Staff  |

Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) are up 16.51% Friday.

As of 11:58:34 est, Intercept sits at $15.88 and has moved $2.285 per share.

Intercept has moved 3.30% over the last 30 days and has a YTD change of 3.93% based on the most recent close.

The company is set to release earnings on 2022-11-03.

For technical charts, analysis, and more on Intercept visit the company profile.

About Intercept Pharmaceuticals Inc

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.

To get more information on Intercept Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Intercept Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan

Market Movers

Sponsored Financial Content